Pathena
ABOUT PATHENA
Pathena is one of Portugal's oldest venture capital firms, founded in 2008 and operating from offices in Porto and Lisbon. It manages roughly €70M and invests from seed through Series A and growth in B2B software, healthcare, enterprise SaaS, and biotech, favouring a patient-capital approach and companies with strong recurring revenue. Pathena's portfolio includes Primetag, Exago, ebankIT, Bizay, Klinik, A-to-Be, and healthcare and imaging ventures such as TNI medical, AI4Med, Biorce, and NVision Imaging Technologies. The firm has recorded four exits, among them the acquisitions of Huub, Neadvance, and Vortal. Pathena is led by Managing Partner and CEO António Murta and Managing Partner and CFO Vitor Dinis, with Jorge Brás as Partner. Its decades of activity in the Portuguese market and its dual Porto-Lisbon presence give Pathena a long track record spanning software and life-sciences companies across multiple stages of growth.
INVESTMENT THESIS
Patient capital. Invests in B2B software and healthcare companies with strong recurring revenue. Decades of experience in the Portuguese market.
INVESTMENT DETAILS
TEAM
CONNECT
FREQUENTLY ASKED QUESTIONS
What stage does Pathena invest at?
Pathena invests at Seed, Series A, Growth stages.
What sectors does Pathena invest in?
Pathena focuses on B2B Software, Healthcare, Enterprise SaaS, Biotech.
Where is Pathena based?
Pathena is a VC based in Porto / Lisbon, Portugal, founded in 2008.
Who are the partners at Pathena?
Key people at Pathena include António Murta (Managing Partner & CEO), Vitor Dinis (Managing Partner & CFO), Jorge Brás (Partner).
What companies has Pathena invested in?
Pathena's portfolio includes Neadvance, Huub, Vortal, 360hyper, Bizay, Klinik, ebankIT, A-to-Be, among others.
How much does Pathena manage?
Pathena manages €70M in assets / fund commitments.
How do I contact or pitch Pathena?
You can reach Pathena via their website (pathena.com). You can also submit your startup through Portugal VC's pitch tool to be forwarded to matching investors.